Quarterly report [Sections 13 or 15(d)]

Schedule of Anti-dilutive Securities (Details)

v3.26.1
Schedule of Anti-dilutive Securities (Details) - shares
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 40,794,172 50,215
Share-Based Payment Arrangement, Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 1,076,312 25,663
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 17,687 24,552
Common Shares Issuable Upon Conversion Of Series F Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 249,624
Common Shares Issuable Upon Conversion Of Warrants Attached To Series H Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 23,925,000
Common Shares Issuable Upon Conversion of Series H Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 15,525,549